DAAAK Pharma Int. AS
Active Registry code 12864378
AS Tallinn Registered 11 Jun 2015
DAAAK Pharma Int. AS is a AS based in Tallinn, registry code 12864378, status: active. Main activity: Wholesale of medicines and other pharmacy goods. According to EMTA, turnover for Q3 2026 was €4 945 470 with 4 employees.
Turnover
4 945 470 €
↑ 77.8% vs Q2 2026
State taxes
16 580 €
↓ 3.5% vs Q2 2026
Labour taxes
17 083 €
↓ 1.5% vs Q2 2026
Employees
4
±0 vs Q2 2026
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 4.9 mn €above 98% of companiesindustry median 60 065 € · companies in the industry: 6 941
- Labour taxes per employee 4 271 €above 79% of companiesindustry median 2 104 € · companies in the industry: 4 194
- Revenue · 2025 7.6 mn €above 98% of companiesindustry median 63 691 € · companies in the industry: 10 038
- Net profit margin · 2025 0.8 %above 38% of companiesindustry median 2.7 % · companies in the industry: 7 414
Taxes and turnover
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 4 945 470 | 16 580 | 17 083 | 4 |
| Q2 2026 | 2 781 743 | 17 175 | 17 341 | 4 |
| Q1 2026 | 5 943 647 | 19 685 | 20 013 | 4 |
| Q4 2025 | 3 001 926 | 18 479 | 17 375 | 4 |
| Q3 2025 | 5 243 814 | 15 226 | 15 726 | 4 |
| Q2 2025 | 2 372 103 | 16 845 | 15 565 | 4 |
| Q1 2025 | 2 756 607 | 69 880 | 17 611 | 4 |
| Q4 2024 | 3 443 542 | 14 334 | 14 692 | 4 |
| Q3 2024 | 3 258 070 | 17 271 | 14 698 | 4 |
| Q2 2024 | 1 854 668 | 31 186 | 21 432 | 4 |
| Q1 2024 | 5 647 545 | 33 886 | 22 558 | 4 |
| Q4 2023 | 6 133 875 | 11 921 | 12 430 | 3 |
| Q3 2023 | 3 462 313 | 16 156 | 10 071 | 3 |
| Q2 2023 | 5 143 057 | 14 467 | 10 006 | 3 |
| Q1 2023 | 4 073 223 | 9 198 | 9 556 | 3 |
| Q4 2022 | 1 823 543 | 23 966 | 9 366 | 3 |
| Q3 2022 | 59 435 | 27 135 | 9 352 | 3 |
| Q2 2022 | 1 872 785 | 11 976 | 9 075 | 3 |
| Q1 2022 | 1 087 916 | 11 327 | 11 793 | 3 |
Labour taxes per employee per month
1 424 €
Turnover per employee in the quarter
1 236 368 €
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 7 565 196 | 60 392 | 286 781 | 3 295 694 | 2 549 374 | 11 |
| 2024 | 10 570 895 | -296 257 | 305 500 | 3 242 530 | 2 488 982 | 15 |
| 2023 | 17 441 725 | 2 489 353 | 244 230 | 8 720 726 | 2 785 239 | 11 |
| 2022 | 4 088 283 | 410 304 | 185 411 | 2 823 971 | 695 886 | 10 |
| 2021 | 4 857 922 | -198 571 | 197 704 | 1 977 424 | 535 592 | 10 |
| 2020 | 4 249 009 | 126 982 | 187 901 | 1 601 990 | 794 163 | 13 |
| 2019 | 3 569 628 | 73 990 | 157 925 | 1 704 863 | 882 695 | 11 |
| 2018 | — | — | — | — | — | 0 |
| 2017 | — | — | — | — | — | 0 |
| 2016 | — | — | — | — | — | 0 |
| 2015 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Net profit margin
0.8 %
Net profit / revenue
Return on equity (ROE)
2.4 %
Net profit / equity
Return on assets (ROA)
1.8 %
Net profit / assets
Equity ratio
77.4 %
Equity / assets
Debt ratio
22.6 %
Liabilities / assets
Current ratio
4.31
Current assets / current liabilities
Revenue per employee
687 745 €
Revenue / average full-time employees
Labour cost per employee per month
2 173 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 17 Apr 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 30 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 17 May 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 27 Apr 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 5 May 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 14 Jun 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 30 Jun 2020 | Company’s own · audited | e-Äriregister |
Board
- Nasdaq CSD SEKeeper of the share ledger · since 28 Sep 2017
- Jelena LernerBoard member · since 13 Aug 2018
Right of representation
Any member of the management board may represent the public limited company in all transactions.
Owners
No owner information.
Beneficial owners
- Jelena LernerDirect ownership · since 10 Jul 2025
Founders and other persons
- Siarhei KastsianFounder · 2 500 € · 3 Jun 2015
- OSAÜHING MN MEDICALFounder · 22 500 € · 3 Jun 2015
- Irina SomovaAudit firm · 18 Jun 2019
- Diana KonstantinovaSupervisory board member · 1 Sep 2023
- Deniss SmoldarevSupervisory board member · 22 Mar 2024
- Kirsan LernerSupervisory board member · 22 Mar 2024
- Omanikukonto: Jelena LernerShareholder · 25 000 € · 21 Jul 2025
Related companies
Activities (EMTAK)
- 46461Wholesale of medicines and other pharmacy goods Main
- 46462Wholesale of medical appliances and surgical and orthopaedic instruments and devices
- 70201Business and other management consultancy activities
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50009789 / 15 9 Jul 2025 |
Second (constitutive) merger entry | In force 9 Jul 2025 |
||
| Ä 50009789 / 14 3 May 2024 |
Amendment entry | In force 3 May 2024 |
||
| Ä 50009789 / M5 2 May 2024 |
Ruling to eliminate deficiencies | 18 May 2024 | Deficiencies eliminated 3 May 2024 |
|
| Ä 50009789 / M4 1 Apr 2024 |
Ruling to correct data outside an entry | 15 Apr 2024 | Deficiencies eliminated 9 Apr 2024 |
|
| Ä 50009789 / M3 18 Apr 2023 |
Ruling to correct data outside an entry | 2 May 2023 | Deficiencies eliminated 21 Apr 2023 |
|
| Ä 50009789 / M2 11 Apr 2023 |
Ruling to correct data outside an entry | 25 Apr 2023 | Deficiencies eliminated 21 Apr 2023 |
|
| Ä 50009789 / 13 13 Oct 2020 |
Amendment entry | In force 13 Oct 2020 |
||
| Ä 50009789 / M1 18 Sep 2020 |
Ruling to eliminate deficiencies | 2 Oct 2020 | Deficiencies eliminated 5 Oct 2020 |
|
| Ä 50009789 / 12 22 Jul 2019 |
Amendment under Commercial Code § 525 (2) | In force 22 Jul 2019 |
||
| Ä 50009789 / 11 13 Aug 2018 |
Amendment entry | In force 13 Aug 2018 |
||
| Ä 50009789 / 10 13 Aug 2018 |
Amendment entry | In force 13 Aug 2018 |
||
| Ä 50009789 / 9 26 Jul 2018 |
Amendment entry | In force 26 Jul 2018 |
||
| Ä 50009789 / 8 28 Jun 2018 |
Amendment entry | In force 28 Jun 2018 |
||
| Ä 50009789 / 7 22 May 2018 |
Amendment entry | In force 22 May 2018 |
||
| Ä 50009789 / 6 20 Jan 2018 |
Amendment entry | In force 20 Jan 2018 |
||
| Ä 50009789 / 5 27 Nov 2017 |
Amendment entry | In force 27 Nov 2017 |
||
| Ä 50009789 / 4 13 Nov 2017 |
Amendment entry | In force 13 Nov 2017 |
||
| Ä 50009789 / 3 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 50009789 / 2 12 Jul 2017 |
Amendment entry | In force 12 Jul 2017 |
||
| Ä 50009789 11 Jun 2015 |
First entry | In force 11 Jun 2015 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data